238 related articles for article (PubMed ID: 22509827)
1. Cathelicidin LL-37: a defense molecule with a potential role in psoriasis pathogenesis.
Dombrowski Y; Schauber J
Exp Dermatol; 2012 May; 21(5):327-30. PubMed ID: 22509827
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions.
Dombrowski Y; Peric M; Koglin S; Kammerbauer C; Göss C; Anz D; Simanski M; Gläser R; Harder J; Hornung V; Gallo RL; Ruzicka T; Besch R; Schauber J
Sci Transl Med; 2011 May; 3(82):82ra38. PubMed ID: 21562230
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis and Antimicrobial Peptides.
Takahashi T; Yamasaki K
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947991
[TBL] [Abstract][Full Text] [Related]
4. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes.
Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY
Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036
[TBL] [Abstract][Full Text] [Related]
5. Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
Zhang LJ
Front Immunol; 2019; 10():1440. PubMed ID: 31293591
[TBL] [Abstract][Full Text] [Related]
6. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands.
Morizane S; Yamasaki K; Mühleisen B; Kotol PF; Murakami M; Aoyama Y; Iwatsuki K; Hata T; Gallo RL
J Invest Dermatol; 2012 Jan; 132(1):135-43. PubMed ID: 21850017
[TBL] [Abstract][Full Text] [Related]
7. [Cathelicidin LL-37. A central factor in the pathogenesis of inflammatory dermatoses?].
Schauber J; Ruzicka T; Rupec RA
Hautarzt; 2008 Jan; 59(1):72-4. PubMed ID: 18209993
[TBL] [Abstract][Full Text] [Related]
8. Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA.
Lande R; Chamilos G; Ganguly D; Demaria O; Frasca L; Durr S; Conrad C; Schröder J; Gilliet M
Eur J Immunol; 2015 Jan; 45(1):203-13. PubMed ID: 25332209
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea.
Salzer S; Kresse S; Hirai Y; Koglin S; Reinholz M; Ruzicka T; Schauber J
J Dermatol Sci; 2014 Dec; 76(3):173-9. PubMed ID: 25306296
[TBL] [Abstract][Full Text] [Related]
10. Topical vitamin D₃ analogues induce thymic stromal lymphopoietin and cathelicidin in psoriatic skin lesions.
Sato-Deguchi E; Imafuku S; Chou B; Ishii K; Hiromatsu K; Nakayama J
Br J Dermatol; 2012 Jul; 167(1):77-84. PubMed ID: 22384824
[TBL] [Abstract][Full Text] [Related]
11. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.
Niyonsaba F; Ushio H; Nagaoka I; Okumura K; Ogawa H
J Immunol; 2005 Aug; 175(3):1776-84. PubMed ID: 16034119
[TBL] [Abstract][Full Text] [Related]
12. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.
Peric M; Koglin S; Kim SM; Morizane S; Besch R; Prinz JC; Ruzicka T; Gallo RL; Schauber J
J Immunol; 2008 Dec; 181(12):8504-12. PubMed ID: 19050268
[TBL] [Abstract][Full Text] [Related]
13. [Cathelicidins: multifunctional defense molecules of the skin].
Peric M; Koglin S; Ruzicka T; Schauber J
Dtsch Med Wochenschr; 2009 Jan; 134(1-2):35-8. PubMed ID: 19090451
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides and the skin immune defense system.
Schauber J; Gallo RL
J Allergy Clin Immunol; 2008 Aug; 122(2):261-6. PubMed ID: 18439663
[TBL] [Abstract][Full Text] [Related]
15. Control of cutaneous antimicrobial peptides by vitamin D3.
Dombrowski Y; Peric M; Koglin S; Ruzicka T; Schauber J
Arch Dermatol Res; 2010 Aug; 302(6):401-8. PubMed ID: 20221619
[TBL] [Abstract][Full Text] [Related]
16. Effect of narrowband ultraviolet B therapy on serum vitamin D and cathelicidin (LL-37) in patients with chronic plaque psoriasis.
Al-Mutairi N; Shaaban D
J Cutan Med Surg; 2014; 18(1):43-8. PubMed ID: 24377473
[TBL] [Abstract][Full Text] [Related]
17. The vitamin D pathway: a new target for control of the skin's immune response?
Schauber J; Gallo RL
Exp Dermatol; 2008 Aug; 17(8):633-9. PubMed ID: 18573153
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial peptides and the skin immune defense system.
Schauber J; Gallo RL
J Allergy Clin Immunol; 2009 Sep; 124(3 Suppl 2):R13-8. PubMed ID: 19720207
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D analogs differentially control antimicrobial peptide/"alarmin" expression in psoriasis.
Peric M; Koglin S; Dombrowski Y; Gross K; Bradac E; Büchau A; Steinmeyer A; Zügel U; Ruzicka T; Schauber J
PLoS One; 2009 Jul; 4(7):e6340. PubMed ID: 19623255
[TBL] [Abstract][Full Text] [Related]
20. Etanercept decreases the innate immune wounding response in psoriasis.
Hata TR; Afshar M; Miller J; Two AM; Kotol P; Jackson M; Alexandrescu DT; Kabigting F; Gerber M; Lai Y; Gallo RL
Exp Dermatol; 2013 Sep; 22(9):599-601. PubMed ID: 23802569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
